Parallel Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Parallel Advisors's VCYT Position: Q1 2026 in Review
Parallel Advisors increased its Veracyte (VCYT) stake by 5.1% in Q1 2026, buying an estimated $222 and bringing the position to 123 shares worth $3.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3125.
Parallel Advisors first reported a position in VCYT in Q2 2019 and has held it in 20 quarters since. The position peaked at $339K in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Parallel Advisors held 123 shares of Veracyte worth $3.96K as of Q1 2026.
- Parallel Advisors bought 6 Veracyte shares in Q1 2026, an estimated $222.
- Veracyte made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3125 holding.
- Parallel Advisors first reported a position in Veracyte in Q2 2019 and has held it in 20 quarters since.
- Parallel Advisors's Veracyte position peaked at $339K in Q4 2024.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.